News

Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...
Fact checked by Nick Blackmer I was first told that I was at higher risk for fatty liver disease in 2005. I had never heard ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Aroosha Sarrafi tells Health her story of getting diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), a ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening steatohepatitis.
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
On a quest to expand the eligible patient pool for its fast-growing liver disease drug Rezdiffra, Madrigal Pharmaceuticals ...